ArticleStudies in family planning2025
Walk the Talk: The Unfinished and Urgent Task of Revising Top-Line Family Planning Indicators, 30 Years After ICPD.
Article in Studies in family planning, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The 1994 International Conference on Population and Development transformed the family planning (FP) field. Yet, three decades later, global FP monitoring remains anchored in the same core indicators: contraceptive use, unmet need, and demand satisfied. Despite decades of well-established critique, these measures have seen little substantive revision. As the global community looks to 2030 and beyond, a coordinated effort is urgently needed to develop a revised set of easily interpretable, top-line FP indicators. Leveraging recent momentum around advances in FP and contraceptive measurement, this effort must be intentional and focused-ensuring that new indicators better reflect the values and priorities of the field-and should be guided by principles of simplicity, validity, directionality, and universal applicability. Without action, the FP community risks continued reliance on outdated measures or the adoption of impractical, unvalidated indicators, weakening future accountability for rights-based FP. We call on key stakeholders-FP advocates, donors, and global organizations-to prioritize and invest in the development and validation of robust new top-line FP indicators over the next three years, to ensure their integration into post-2030 global agenda setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.